APOC2 and Huntington disease: A panel of four proteins identified by MS analysis in all seven HD patients (two upregulated [apoC-II and apoC-III] and two downregulated [serotransferrin and haptoglobin]) was selected to confirm the changes in the protein expression that was observed in the proteomic analysis.